Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
$30K Buy
592
+424
+252% +$22.9K 0.04% 101
2017
Q4
$9K Sell
168
-503
-75% -$27.9K 0.01% 229
2017
Q3
$40K Sell
671
-119
-15% -$7.21K 0.05% 194
2017
Q2
$48K Buy
790
+499
+171% +$30.4K 0.48% 40
2017
Q1
$17K Buy
+291
New +$17.7K 0.05% 383
2015
Q1
Sell
-461
Closed -$25K 396
2014
Q4
$25K Buy
+461
New +$25.7K 0.03% 152

Other funds holding MRK

FNY Managed Accounts's MRK Position: Q1 2018 in Review

FNY Managed Accounts increased its Merck (MRK) stake by 252% in Q1 2018, buying an estimated $22.9K and bringing the position to 592 shares worth $30K. The position accounts for 0.04% of the portfolio, ranked #101.

FNY Managed Accounts first reported a position in MRK in Q4 2014 and has held it in 6 quarters since. The position peaked at $48K in Q2 2017. 1,993 funds tracked by Wall St. Rank hold MRK as of Q1 2018.

  • FNY Managed Accounts held 592 shares of Merck worth $30K as of Q1 2018.
  • FNY Managed Accounts bought 424 Merck shares in Q1 2018, an estimated $22.9K.
  • Merck made up 0.04% of FNY Managed Accounts's portfolio in Q1 2018, its #101 holding.
  • FNY Managed Accounts first reported a position in Merck in Q4 2014 and has held it in 6 quarters since.
  • FNY Managed Accounts's Merck position peaked at $48K in Q2 2017.
  • 1,993 funds tracked by Wall St. Rank held Merck as of Q1 2018.

Based on FNY Managed Accounts's 13F filing for Q1 2018, filed 18 Apr 2018.